Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-13 Sale | 2024-12-13 6:28 pm | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 50,000 | $164.8 | $8,240,023 | 3,153,144 (Indirect Direct) | View |
| 2024-09-12 Sale | 2024-09-13 5:45 pm | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 50,000 | $197.77 | $9,888,276 | 3,203,144 (Indirect Direct) | View |
| 2024-06-11 Sale | 2024-06-11 8:33 pm | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 50,000 | $175.76 | $8,788,062 | 3,253,144 (Indirect Direct) | View |
| 2024-03-11 Sale | 2024-03-11 8:27 pm | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 50,000 | $170.95 | $8,547,719 | 3,303,144 (Indirect Direct) | View |
| 2023-12-11 Sale | 2023-12-12 5:23 pm | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 50,000 | $105.67 | $5,283,291 | 3,348,544 (Indirect Direct) | View |
| 2023-09-11 Sale | 2023-09-12 6:01 pm | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 50,000 | $127.23 | $6,361,680 | 3,398,544 (Indirect Direct) | View |
| 2023-05-31 Sale | 2023-06-02 6:23 pm | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 50,000 | $116.2 | $5,809,889 | 3,448,544 (Indirect Direct) | View |
| 2023-04-17 Sale | 2023-04-18 4:08 pm | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 50,000 | $87.65 | $4,382,424 | 3,502,894 (Indirect Direct) | View |
| 2023-01-17 Sale | 2023-01-19 5:44 pm | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 50,000 | $80.79 | $4,039,744 | 3,555,951 (Indirect Direct) | View |
| 2023-01-04 Sale | 2023-01-05 6:10 pm | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 7,686 | $80.08 | $615,525 | 3,605,951 (Indirect Direct) | View |
| 2022-12-29 Sale | 2023-01-03 6:44 pm | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 19,422 | $80.34 | $1,560,411 | 3,613,637 (Indirect Direct) | View |
| 2022-12-16 Sale | 2022-12-20 5:23 pm | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 21,099 | $80.1 | $1,689,986 | 3,633,059 (Indirect Direct) | View |
| 2022-11-23 Sale | 2022-11-28 6:26 pm | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 4 | $80.01 | $320 | 3,654,158 (Indirect Direct) | View |
| 2022-11-08 Sale | 2022-11-10 5:05 pm | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 1,789 | $80.05 | $143,201 | 3,654,162 (Indirect Direct) | View |
| 2022-08-05 Sale | 2022-08-09 4:59 pm | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 50,000 | $81.18 | $4,058,825 | 3,655,951 (Indirect Direct) | View |
| 2021-12-10 Sale | 2021-12-14 4:14 pm | Krystal Biotech Inc. | KRYS | Krishnan Suma Chief Operating Officer 10% Owner | 100,000 | $70.5 | $7,050,000 | 3,696,850 (Indirect Direct) | View |
| 2020-09-15 Sale | 2020-09-17 6:35 pm | Krystal Biotech Inc. | KRYS | Krishnan Suma Chief Operating Officer 10% Owner | 50,000 | $46.37 | $2,318,629 | 3,834,688 (Indirect Direct) | View |
| 2020-06-15 Sale | 2020-06-17 4:14 pm | Krystal Biotech Inc. | KRYS | Krishnan Suma Chief Operating Officer 10% Owner | 50,000 | $43.5 | $2,174,775 | 3,884,688 (Indirect Direct) | View |
| 2020-03-16 Sale | 2020-03-18 8:14 pm | Krystal Biotech Inc. | KRYS | Krishnan Suma Chief Operating Officer 10% Owner | 15,398 | $40.49 | $623,412 | 3,984,688 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-28 Exercise | 2024-03-01 8:13 pm | N/A N/A | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 20,000 | $0 | 3,405,644 (Direct) | View |
| 2024-02-28 Tax Withholding | 2024-03-01 8:13 pm | N/A N/A | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 9,256 | $163.08 | 3,405,644 (Direct) | View |
| 2024-02-29 Option Award | 2024-03-01 8:13 pm | N/A N/A | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 45,000 | $0 | 3,405,644 (Direct) | View |
| 2024-02-26 Tax Withholding | 2024-02-28 9:39 pm | N/A N/A | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 2,353 | $157 | 3,346,191 (Direct) | View |
| 2023-02-26 Tax Withholding | 2023-02-28 6:41 pm | N/A N/A | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 3,057 | $78.46 | 3,597,894 (Direct) | View |
| 2023-02-28 Option Award | 2023-02-28 6:41 pm | N/A 2033-02-28 | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 45,000 | $0 | 3,597,894 (Direct) | View |
| 2022-02-26 Tax Withholding | 2022-03-01 9:20 pm | N/A N/A | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 3,282 | $62.5 | 3,755,951 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-01 9:20 pm | N/A 2032-02-28 | Krystal Biotech Inc. | KRYS | Krishnan Suma President, R&D 10% Owner | 50,000 | $0 | 3,755,951 (Direct) | View |
| 2021-02-26 Option Award | 2021-03-02 8:42 pm | N/A 2025-02-26 | Krystal Biotech Inc. | KRYS | Krishnan Suma Chief Operating Officer 10% Owner | 71,000 | $0 | 3,946,488 (Direct) | View |